Stephen Gracon

525 total citations
11 papers, 428 citations indexed

About

Stephen Gracon is a scholar working on Psychiatry and Mental health, Economics and Econometrics and Physiology. According to data from OpenAlex, Stephen Gracon has authored 11 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Economics and Econometrics and 4 papers in Physiology. Recurrent topics in Stephen Gracon's work include Dementia and Cognitive Impairment Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Alzheimer's disease research and treatments (4 papers). Stephen Gracon is often cited by papers focused on Dementia and Cognitive Impairment Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Alzheimer's disease research and treatments (4 papers). Stephen Gracon collaborates with scholars based in United States. Stephen Gracon's co-authors include David S. Knopman, Margaret J. Knapp, Charles S. Davis, Mark R. Emmerling, Alex E. Roher, Yu‐Min Kuo, Sheela Talwalker, Dale F. Kraemer, Faye A. Luscombe and James P. Symons and has published in prestigious journals such as Neurology, Dementia and Geriatric Cognitive Disorders and Alzheimer Disease & Associated Disorders.

In The Last Decade

Stephen Gracon

11 papers receiving 398 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen Gracon United States	9	159	150	147	55	53	11	428
Pamela Cyrus United States	7	192 1.2×	190 1.3×	129 0.9×	46 0.8×	42 0.8×	8	386
Martin Farlow United States	6	189 1.2×	301 2.0×	180 1.2×	68 1.2×	110 2.1×	10	565
Kara Lee Shirley United States	4	113 0.7×	182 1.2×	67 0.5×	26 0.5×	57 1.1×	5	392
M Maggini Italy	7	159 1.0×	99 0.7×	108 0.7×	49 0.9×	52 1.0×	14	385
G Sędek Switzerland	15	184 1.2×	213 1.4×	85 0.6×	48 0.9×	51 1.0×	26	659
Friedhoff United States	11	302 1.9×	434 2.9×	64 0.4×	54 1.0×	89 1.7×	11	730
Tiseo United States	9	204 1.3×	311 2.1×	46 0.3×	39 0.7×	46 0.9×	9	468
Aaron P. Webb United States	3	104 0.7×	216 1.4×	149 1.0×	58 1.1×	84 1.6×	4	448
P. Tariska Hungary	4	243 1.5×	67 0.4×	152 1.0×	78 1.4×	58 1.1×	7	470
John B. Standridge United States	8	39 0.2×	88 0.6×	105 0.7×	39 0.7×	69 1.3×	16	412

Countries citing papers authored by Stephen Gracon

Since Specialization

Citations

This map shows the geographic impact of Stephen Gracon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Gracon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Gracon more than expected).

Fields of papers citing papers by Stephen Gracon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Gracon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Gracon. The network helps show where Stephen Gracon may publish in the future.

Co-authorship network of co-authors of Stephen Gracon

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Gracon. A scholar is included among the top collaborators of Stephen Gracon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Gracon. Stephen Gracon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Dolgachev, Vladislav, et al.. (2015). Nanoemulsion Therapy for Burn Wounds Is Effective as a Topical Antimicrobial Against Gram-Negative and Gram-Positive Bacteria. Journal of Burn Care & Research. 37(2). e104–e114. 21 indexed citations

Roher, Alex E., et al.. (1999). Amyloid and lipids in the pathology of Alzheimer disease. Amyloid. 6(2). 136–145. 60 indexed citations

Emmerling, Mark R., Katharyn Spiegel, Edward D. Hall, et al.. (1999). Emerging strategies for the treatment of Alzheimer’s disease at the Millennium. 4(1). 35–86. 1 indexed citations

Gracon, Stephen, Margaret J. Knapp, Mark Pierce, et al.. (1998). Safety of Tacrine: Clinical Trials, Treatment IND, and Postmarketing Experience. Alzheimer Disease & Associated Disorders. 12(2). 93–101. 84 indexed citations

Schneider, Lon S., et al.. (1997). Tacrine and nursing home placement. Neurology. 49(3). 898–899. 1 indexed citations

Foster, Norman L., et al.. (1996). An Enriched-Population, Double-Blind, Placebo-Controlled, Crossover Study of Tacrine and Lecithin in Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 7(5). 260–266. 13 indexed citations

Talwalker, Sheela, et al.. (1996). Cardinal Features of Cognitive Dysfunction in Alzheimer's Disease: A Factor-Analytic Study of the Alzheimer's Disease Assessment Scale. Journal of Geriatric Psychiatry and Neurology. 9(1). 39–46. 23 indexed citations

Smith, Fraser, et al.. (1996). The use of survival analysis techniques in evaluating the effect of long-term tacrine (cognex^®) treatment on nursing home placement and mortality in patients with. Journal of Biopharmaceutical Statistics. 6(4). 395–409. 12 indexed citations

Knopman, David S. & Stephen Gracon. (1994). Observations on the short‐term 'natural history' of probable Alzheimer's disease in a controlled clinical trial. Neurology. 44(2). 260–260. 19 indexed citations

10.

Knopman, David S., Margaret J. Knapp, Stephen Gracon, & Charles S. Davis. (1994). The Clinician Interview‐ Based Impression (CIBI). Neurology. 44(12). 2315–2315. 168 indexed citations

11.

Gamzu, Elkan, et al.. (1989). Recent development in 2‐pyrrolidinone‐containing nootropics. Drug Development Research. 18(3). 177–189. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact